Marrying the Business with the Science

Summary

In this episode of the Venrock podcast "Running Through Walls," Sam Kulkarni, PhD, CEO of CRISPR Therapeutics, explains how gene‑editing technology is being pursued as a near‑science‑fiction cure and the business strategies behind it. He offers practical advice on raising capital in the high‑cost biotech sector, emphasizing the need for boldness, resilience against skeptics, and leveraging market volatility as opportunity. The conversation blends scientific ambition with real‑world entrepreneurial tactics, illustrating how cutting‑edge science can be married to effective business leadership.